Free Trial

International Biotechnology (IBT) Insider Trading & Ownership

International Biotechnology logo
GBX 684 +10.00 (+1.48%)
(As of 12/20/2024 11:48 AM ET)

International Biotechnology (LON:IBT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.18%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
£20,670.63
Number Of
Insiders Selling
(Last 12 Months)
0
Get IBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling International Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IBT Insider Buying and Selling by Quarter

International Biotechnology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/17/2024Katherine Cornish-BowdenInsiderBuy1,500GBX 713£10,695
7/24/2024Gillian ElcockInsiderBuy1,407GBX 709£9,975.63
(Data available from 1/1/2013 forward)

IBT Insider Trading Activity - Frequently Asked Questions

The list of insiders at International Biotechnology includes Caroline Gulliver, Gillian Elcock, Katherine Cornish-Bowden, Patrick Magee, and Patrick Maxwell. Learn more on insiders at IBT.

4.18% of International Biotechnology stock is owned by insiders. Learn more on IBT's insider holdings.

The following insiders have purchased IBT shares in the last 24 months: Caroline Gulliver (£14,325), Gillian Elcock (£9,975.63), and Katherine Cornish-Bowden (£20,190).

Insiders have purchased a total of 6,907 IBT shares in the last 24 months for a total of £44,490.63 bought.

International Biotechnology Key Executives

  • Ms. Catherine Elizabeth Bingham M.B.A. (Age 58)
    Managing Partner
  • Claire Jackson
    Company Secretary
  • Dr. Carl Harald Janson
    Lead Investment Manager


This page (LON:IBT) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners